DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox (Botulinum Toxin Type A) - Adverse Event Reports - Serious Event - Botulism

 



Index of reports > Cases resulting in a serious event (101) > Cases with Botulism (15)

Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in a serious event where reactions include botulism.

Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-24

Patient: male

Adverse reactions / side effects: Botulism

Suspect drug(s):
Botox
    Indication: Muscle Spasticity

Botox
    Indication: Cerebral Palsy



Adverse event in 24 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a individual with unspecified qualification from United States on 2007-10-23

Patient: 24 year old female

Adverse reactions / side effects: Botulism

Adverse event resulted in: life threatening event

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-22

Patient: female, weighing 11.8 kg (26.0 pounds)

Adverse reactions / side effects: Overdose, Botulism

Suspect drug(s):
Botox
    Dosage: 400 units, single
    Indication: Muscle Spasticity

Botox
    Indication: Cerebral Palsy



Adverse event in receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-22

Patient:

Adverse reactions / side effects: Botulism

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-07-13

Patient: male, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-22

Patient: male, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-15

Patient: male, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: male, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium



Adverse event in 2 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-02

Patient: 2 year old female, weighing 14.0 kg (30.8 pounds)

Adverse reactions / side effects: Dysphagia, Gastroenteritis Rotavirus, Muscular Weakness, Eyelid Ptosis, Botulism

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 160 units, single
    Indication: Quadriparesis
    Start date: 2007-05-08
    End date: 2007-05-08

Botox

Botox

Other drugs received by patient: Keppra



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-01

Patient: male, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium



Adverse event in 60 year old male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-05-31

Patient: 60 year old male, weighing 86.2 kg (189.6 pounds)

Adverse reactions / side effects: Dyspnoea, Dysphagia, Paralysis, Vocal Cord Paralysis, Headache, Botulism, Speech Disorder, Muscle Strain, Fatigue, Dysphonia, Oesophageal Disorder, Heart Rate Increased, Vasodilatation, Tracheal Disorder, Asthenia

Adverse event resulted in: life threatening event

Suspect drug(s):
Botox
    Dosage: 400 units one time im
    Indication: Muscle Spasms
    Start date: 2007-02-06
    End date: 2007-02-06

Botox
    Dosage: 400 units one time im
    Indication: Musculoskeletal Pain
    Start date: 2007-02-06
    End date: 2007-02-06

Botox
    Dosage: 400 units one time im
    Indication: Neck Pain
    Start date: 2007-02-06
    End date: 2007-02-06



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-05-25

Patient: male, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium



Adverse event in 2 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-05-24

Patient: 2 year old female, weighing 14.0 kg (30.8 pounds)

Adverse reactions / side effects: Dysphagia, Muscular Weakness, Eyelid Ptosis, Botulism

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 160 units, single
    Indication: Quadriparesis
    Start date: 2007-05-08
    End date: 2007-05-08

Botox

Botox



Adverse event in receiving Botox (Botulinum Toxin Type A)

Reported by a pharmacist from United States on 2007-05-21

Patient:

Adverse reactions / side effects: Therapeutic Product Contamination, Pharmaceutical Product Complaint, Botulism

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in 12 year old male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-05-18

Patient: 12 year old male

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009